OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ALKBH5 ameliorated liver fibrosis and suppressed HSCs activation via triggering PTCH1 activation in an m6A dependent manner
Jing‐Jing Yang, Juan Wang, Yang Yang, et al.
European Journal of Pharmacology (2022) Vol. 922, pp. 174900-174900
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 32

ALKBH5‐mediated m6A demethylation of TIRAP mRNA promotes radiation‐induced liver fibrosis and decreases radiosensitivity of hepatocellular carcinoma
Yuhan Chen, Peitao Zhou, Yixun Deng, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 30

The emerging importance role of m6A modification in liver disease
Sheng Wang, Songsen Gao, Wufei Ye, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114669-114669
Open Access | Times Cited: 30

ALKBH5 attenuates mitochondrial fission and ameliorates liver fibrosis by reducing Drp1 methylation
Juan Wang, Yang Yang, Feng Sun, et al.
Pharmacological Research (2022) Vol. 187, pp. 106608-106608
Open Access | Times Cited: 33

DNA 5mC and RNA m6A modification successively facilitates the initiation and perpetuation stages of HSC activation in liver fibrosis progression
Yue Feng, Shihui Guo, Yulan Zhao, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1211-1220
Closed Access | Times Cited: 20

N6-methyladenosine RNA methylation in liver diseases: from mechanism to treatment
Lan Yang, Siyuan Tian, Xiaohong Zheng, et al.
Journal of Gastroenterology (2023) Vol. 58, Iss. 8, pp. 718-733
Closed Access | Times Cited: 15

RNA modifications in the progression of liver diseases: from fatty liver to cancer
Simiao Li‐Sauerwine, Wajahat Z. Mehal, Xinshou Ouyang
Science China Life Sciences (2024) Vol. 67, Iss. 10, pp. 2105-2119
Open Access | Times Cited: 4

N6-methyladenosine (m6A) RNA modification in fibrosis and collagen-related diseases
Man Tan, Siyi Liu, Lubin Liu
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4

m6A RNA modification pathway: orchestrating fibrotic mechanisms across multiple organs
Xiangfei Huang, Zilu Yu, Juan Tian, et al.
Briefings in Functional Genomics (2025) Vol. 24
Closed Access

The interactive role of microRNA and other non-coding RNA in hepatitis B (HBV) associated fibrogenesis
Kurt Sartorius, Ying Wang, Benn Sartorius, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access

Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis
Shiyi Lyu, Wang Xiao, Guangzu Cui, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 10

Changes in m6A in Steatotic Liver Disease
Belinda J. Petri, Matthew C. Cave, Carolyn M. Klinge
Genes (2023) Vol. 14, Iss. 8, pp. 1653-1653
Open Access | Times Cited: 10

Integrative analysis implicates the significance of m6A in the liver fibrosis of biliary atresia by regulating THY1
Junfeng Wang, Min Du, Lingdu Meng, et al.
Hepatology Communications (2023) Vol. 7, Iss. 1, pp. e0004-e0004
Open Access | Times Cited: 9

Sodium arsenite induces hepatic stellate cells activation by m6A modification of TGF-β1 during liver fibrosis
Tianming Qiu, Kun Hou, Jingyuan Zhang, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 278, pp. 116435-116435
Open Access | Times Cited: 3

The Epigenetic Regulation of RNA N6-Methyladenosine Methylation in Glycolipid Metabolism
Haiqing Yang, Yuting Li, Linying Huang, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 273-273
Open Access | Times Cited: 8

Emerging role of m6A modification in fibrotic diseases and its potential therapeutic effect
Wufei Ye, Xiongwen Lv, Songsen Gao, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115873-115873
Closed Access | Times Cited: 7

Insight into the regulatory mechanism of m6A modification: From MAFLD to hepatocellular carcinoma
Xuan Zha, Zewei Gao, Min Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116966-116966
Open Access | Times Cited: 2

FTO-mediated m<sup>6</sup>A demethylation of ULK1 mRNA promotes autophagy and activation of hepatic stellate cells in liver fibrosis
Tingjuan Huang, Chunhong Zhang, Junjie Ren, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access | Times Cited: 1

KDM4C represses liver fibrosis by regulating H3K9me3 methylation of ALKBH5 and m6A methylation of snail1 mRNA
Hua Zhou, Bing Qing Wang, M. Chen, et al.
Journal of Digestive Diseases (2024) Vol. 25, Iss. 5, pp. 298-309
Closed Access | Times Cited: 1

m6A epitranscriptomic and epigenetic crosstalk in liver fibrosis: Special emphasis on DNA methylation and non-coding RNAs
Qi-Qi Dong, Yang Yang, Hui Tao, et al.
Cellular Signalling (2024) Vol. 122, pp. 111302-111302
Closed Access | Times Cited: 1

The role of RNA m6A demethylase ALKBH5 in the mechanisms of fibrosis
Ziwei Liao, Jing Wang, Mengrou Xu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1

ALKBH5 Protects Against Hepatic Ischemia–Reperfusion Injury by Regulating YTHDF1-Mediated YAP Expression
Pi‐Xiao Wang, Mei Xiang, Ling Zhu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11537-11537
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top